Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

POLY MEDICURE LTD. - 531768 - Disclosure Of Material Impact Of COVID-19 Pandemic On Company

 Dear Sir/Madam, In continuation of our earlier announcement dated 22nd May, 2020 regarding the material impact of CoVID-19 pandemic on Company and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed further details as required under SEBI (Listing Obligations and disclosure requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated 20th May 2020. Kindly take the enclosed information on record.
27-05-2020
Bigul

POLY MEDICURE LTD. - 531768 - Board to consider Final Dividend

 Poly Medicure Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on June 05, 2020, inter alia, to consider the following:1. To consider and approve the Audited Financial Results (Consolidated & Standalone) of the Company for the financial year ended on March 31, 2020.2. To consider recommendation of Final Dividend, if any, on the Equity Shares for the financial year ended on March 31, 2020.In continuation of our intimation regarding closure of trading window vide letter dated March 31, 2020, the Trading Window for dealing in securities of the Company shall remain closed till June 07, 2020.
25-05-2020
Bigul

POLY MEDICURE LTD. - 531768 - Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On 5Th June, 2020

 POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2020 ,inter alia, to consider and approve Dear Sir/Madam, Pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, the 5th June, 2020, inter alia to consider the following: a) To consider and approve the Audited Financial Results (Consolidated & Standalone) of the Company for the financial year ended on 31st March, 2020. b) To consider recommendation of Final Dividend, if any, on the Equity Shares for the financial year ended on 31st March, 2020. c) To transact any other matter which the Board may deem fit. In continuation of our intimation regarding closure of trading window vide letter dated 31st March, 2020, the Trading Window for dealing in securities of the Company shall remain closed till 7th June, 2020. This is for your information and record. Thanking You Avinash Chandra Company Secretary
25-05-2020
Bigul

POLY MEDICURE LTD. - 531768 - Disclosure Of Material Impact Of Covid-19 Pandemic On Company Under Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84

 Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated 20th May, 2020, we would like to inform you that the Company's main business is manufacturing of medical devices, which comes under the essentials services as per ministry of Home Affairs Order No. 40-3/2020-DM-I(A) dated 24th March, 2020 and which were exempted from lockdown. The Company has also taken extensive steps to ensure the safety and welfare of its employees at its plants and offices. There is no major adverse impact of COVID-19 on the Company's business operations. Also, As per Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated 20th May, 2020; we are evaluating the impact of the CoVID-19 pandemic on business, performance and financials, both qualitatively and quantitatively, to the extent possible and will disseminate the same in due course. Kindly take the above information on record.
22-05-2020
Bigul

POLY MEDICURE LTD. - 531768 - Shareholding for the Period Ended March 31, 2020

 Poly Medicure Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here
08-05-2020
Bigul

POLY MEDICURE LTD. - 531768 - Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Period 31St March, 2020.

 Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained by the Company's Registrar and Share Transfer Agent, viz., Mas Services Limited, which is a SEBI approved category-I, Registar & Transfer Agent, registered with Securities and Exchange Board of India (SEBI Registration Number : INR000000049).
05-05-2020
Bigul

POLY MEDICURE LTD. - 531768 - Statement Of Investor Complaints For The Quarter Ended March 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- AVINASH CHANDRADesignation :- Company Secretary and Compliance Officer
23-04-2020
Bigul

POLY MEDICURE LTD. - 531768 - Submission Of Certificate Under Regulation 40(9) Of SEBI(Listing Obligations And Disclosure Requirements) Regulations, 2015 For Half Year Ended On 31St March, 2020

 Pursuant to the regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, please find attached the certificate issued by practicing Company Secretary for the half year ended on 31st March, 2020.
23-04-2020
Bigul

POLY MEDICURE LTD. - 531768 - Closure of Trading Window

 It may please be noted that in compliance with the SEBI (Prohibition to Insider Trading) Regulations, 2015 as amended by the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 read with clarification given by BSE Circular Ref No.: LIST/COMP/01/2019-20 dated 02.04.2019 and NSE letter ref no: NSE/CML/2019/11 dated 02.04.2019 read with Company''s Code of Conduct for prevention of Insider Trading, the Trading Window of the Company has been kept closed for designated person from Wednesday, the 1st April, 2020 till the end of 48 hours after the declaration of Financial Results for the quarter and year ended on 31st March, 2020. The date of the Board Meeting to consider the above financial results would be intimated to the Stock Exchange in due course. You are hereby requested to please take the above information on your records.
31-03-2020
Bigul

POLY MEDICURE LTD. - 531768 - Intimation Of Incorporation Of Wholly Owned Subsidiary Company.

 With reference to captioned subject, we would like to inform you that the Company has incorporated a wholly owned subsidiary company 'PLAN1 HEALTH INDIA PRIVATE LIMITED' on 25.02.2020.
26-02-2020
Next Page
Close

Let's Open Free Demat Account